Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details Narrative)

v3.10.0.1
SUBSEQUENT EVENTS (Details Narrative)
Jan. 22, 2019
Jan. 02, 2019
USD ($)
Jan. 18, 2019
$ / shares
shares
Dec. 31, 2018
$ / shares
shares
Sep. 30, 2018
$ / shares
shares
Common stock, issued | shares       2,829,248 2,829,248
Common stock, par value (in dollars per share) | $ / shares       $ 0.0001 $ 0.0001
Subsequent Event [Member]          
Ownership allocation after merger of Company's common stock   20.00%      
Percent increase (decrease) in ownership allocation for excess proceeds   (0.10%)      
Termination fee of merger agreement to be paid   $ 250,000      
Common stock, issued | shares     56,466,428    
Common stock, par value (in dollars per share) | $ / shares     $ 0.0001    
Reverse stock split ratio .05        
Subsequent Event [Member] | NeuBaseTherapuetics, Inc.          
Ownership allocation after merger of Company's common stock   80.00%      
Percent increase (decrease) in ownership allocation for excess proceeds   0.10%      
Termination fee of merger agreement to be paid   $ 250,000      
Subsequent Event [Member] | NeuBaseTherapuetics, Inc. | Dr. Jason Slakter [Member]          
Retention bonus amount   75,000      
Subsequent Event [Member] | NeuBaseTherapuetics, Inc. | Minimum [Member]          
Amount of entity's equity securities to be issued or sold prior to merger   4,000,000      
Excess proceeds of minimum amount of equity securities to be issued or sold prior to merger   $ 100,000